Delivery Order SPE2DB22D9367-SPE2DB25FSY65
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,783.32 to DMS Pharmaceutical Group Inc. for Daunorubicin 20 mg/4 ml vials on August 8, 2025, with an ultimate completion date of August 11, 2025. This firm fixed-price delivery order represents a pharmaceutical supply requirement for an oncology medication used in cancer treatment protocols. The award was issued without a set-aside designation, allowing DMS Pharmaceutical Group to compete directly based on its capabilities as a...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $3,566.64 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Daunorubicin 20 mg/4 ml vials. The award, issued on August 7, 2025, with an ultimate completion date of August 8, 2025, represents a standard pharmaceutical supply delivery with no set-aside designation applied. DMS Pharmaceutical Group will perform the work at its...
- This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $11,692.95 contract is for the delivery of 4,567,994,749 units of the MENQUADFI VIAL 0.5ML medical product. The contract has an ultimate completion date of April 17, 2025. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the...
- This firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,449.60 award is for the delivery of 4563373091 - Doxorubicin 50 mg/25 ml Vial 25 ml, a chemotherapy medication. The contract is part of DMS Pharmaceutical Group's larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999 and running...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, worth up to $35,995.42, has a completion date of July 2, 2024 and is not set aside. DMS Pharmaceutical Group provides a wide range of pharmaceutical products and medical supplies to support the recurring medical needs of military health facilities and VA medical...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is valued at up to $45,597.60 and has an ultimate completion date of October 7, 2020. DMS Pharmaceutical Group is a key supplier in the federal pharmaceutical supply chain, providing a wide range of pharmaceutical products and medical supplies to support the recurring medical needs of military...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, valued at up to $18,526.83, is for the supply of a variety of pharmaceutical products and medical supplies, including flumazenil injections, prednisone tablets, ampicillin injections, clotrimazole cream, epinephrine auto-injectors, contraceptives, oncology drugs, and other generic...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract has a ceiling value of $4,169.59 and runs through April 30, 2024. DMS Pharmaceutical Group will provide the DLA with a variety of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract has a total ceiling value of $26,298.16 and an ultimate completion date of January 16, 2025. The contract covers the procurement of a range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $6,518.40 contract is for the provision of a variety of pharmaceutical products and medical supplies to support the recurring medical needs of military health facilities worldwide under the DLA's Medical Supply Chain division. DMS Pharmaceutical Group holds a single-award indefinite...
- SPE2DB22D9367Indefinite Delivery Contract
- SPE2DB22D9367-SPE2DB25FSY65Delivery Order
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the supply of 4,568,739,949 units of the drug daunorubicin 20 mg/4 ml vial, with a total ceiling value of $1,188.88. The contract has an ultimate completion date of July 1, 2025. DMS Pharmaceutical Group Inc. is an established pharmaceutical wholesaler that specializes in providing a range of medical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to federal healthcare facilities. The company holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026, which enables the agency to issue firm fixed-price delivery orders for a comprehensive portfolio of pharmaceutical items.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 6/30/25 |